Centre for Policy on Ageing
 

 
Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation
 — Stroke Prevention in Atrial Fibrillation II Study
Corporate AuthorStroke Prevention in Atrial Fibrillation Investigators
Journal titleThe Lancet, vol 343, no 8899, 19 March 1994
Pagespp 687-691
KeywordsStroke ; Thrombosis ; Drugs.
AnnotationThe Stroke Prevention in Atrial Fibrillation II Study (SPAF II) aimed to define the benefits and risks associated with warfarin compared with aspirin in a large number of patients followed for longer, according to age and inherent risk of thromboembolism. (RH).
Accession NumberCPA-940328005 A
ClassmarkCQA: CQJ: LLD *

Data © Centre for Policy on Ageing
...from the Ageinfo database published by Centre for Policy on Ageing.
 
CPA home >> Ageinfo Database >> Queries to: webmaster@cpa.org.uk